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ways.	Our	 study	 reveals	 a	 previously	 unrecognized	 health	 concern	 due	 to	ADSCs	
from old donors and lays the foundation for a new avenue of research to devise 
interventions	to	reduce	harmful	effects	of	ADSCs	from	old	donors.
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Adipose-derived	 mesenchymal	 stem	 cells	 (ADSCs)	 or	 “preadipo-
cytes” have been increasingly suggested for use in regenerative 









cause unexpected or even harmful effects in recipients. This is espe-
cially	important	for	older	adults,	since	they	tend	to	be	more	vulnera-




from young or old donors i.p.	into	syngeneic	20-month-old	C57BL/6	













from	old	donors	can	 induce	physical	 frailty,	which	 is	highly	associ-
ated	with	morbidity	and	loss	of	independence(Ensrud	et	al.,	2009).	




arrest	 caused	 by	 various	 stresses	 (Campisi	 &	 d'Adda	 di	 Fagagna,	
2007)	induces	physical	dysfunction	in	mice	(Xu	et	al.,	2018).	To	de-
fine	 a	 potential	 naturally	 occurring	 senescent	 cell-like	 population,	
we	conducted	single-cell	transcriptome	(SCT)	analysis.	We	obtained	





both of which were highly expressed in cells isolated from the old 
donors	(Figure	2a).	We	manually	set	a	cutoff	of	p21	expression	level,	
which is a higher expression level than in 97% of cells from young 
donors.	We	 considered	 cells	 to	 be	p21high if their p21 levels were 
higher	than	this	cutoff.	We	found	that	8.9%	of	cells	from	old	donors	
were p21high	compared	with	3%	of	cells	in	young	donors	(Figure	2a),	
both of which are similar to the percentages of senescent cells 
observed	in	ADSCs	isolated	from	young	and	old	human	donors	(Xu	
et	al.,	2015).	We	used	p21 rather than p16 because the difference of 
p21 levels between young and old cells was more significant than p16 
(Figure	2a,c)	and	p16 level positively correlates with p21 in p21high 
cells (p	<	.001).	In	addition,	we	found	that	cells	from	old	donors	pro-
liferated	at	a	slower	rate	and	contained	more	SA-βgal+ and p21high 
cells	compared	with	the	cells	from	young	donors	(Figure	S2),	which	is	
consistent with an increased abundance of senescent cells among the 
cells	isolated	from	the	old	donors.	Notably,	we	documented	the	tran-
scriptomic signatures of naturally occurring p21high	 senescent-like	
cells for the first time. By comparing all the distinctly expressed 
genes	within	this	population	using	Ingenuity	Pathway	Analysis	(IPA),	
we	observed	altered	upstream	regulators	and	pathways	(Figure	2b)	
in these naturally occurring p21high cells that are similar to those of 
in	 vitro-generated	 “artificial”	 senescent	 cells,	 including	 Senescent	




pathways. These findings suggest that p21high cells might contribute 
to the physical dysfunction and validate the physiological relevance 
of	the	in	vitro-generated	senescent	cells	that	have	been	extensively	
used to study the biology of senescence and for drug screening. To 
gain	more	 insight	 into	 deleterious	 effects	 of	 aging	on	 the	ADSCs,	
we	 compared	 transcriptomes	 of	 ADSCs	 isolated	 from	 young	 ver-
sus	old	donors	using	edgeR	(Robinson,	McCarthy,	&	Smyth,	2010).	 
Among	15,565	detected	 genes,	 3,787	were	up-regulated	 and	948	
were	down-regulated	(–log10P	value	>	4)	in	the	cells	from	old	donors	
(Figure	2c	and	Supporting	dataset).	Several	senescence-associated	
secretory	 phenotype	 (SASP)-related	 genes	 were	 up-regulated	 in	
cells	 from	old	donors	 (Figure	2c).	 For	 validation,	we	measured	 se-





young	 versus	 old	 donors	 (Figure	 2e),	 affording	 an	 opportunity	 to	
develop	 interventions	 that	could	 reverse	aged	ADSCs	 into	a	more	
“youthful”	state,	potentially	reducing	harmful	effects	and	improving	
regenerative	efficacy.	One	 limitation	of	our	 study	 is	 that	we	used	
allogenic transplantation (although the donors and the recipients 
were	syngeneic),	which	might	not	fully	represent	autologous	trans-









occurring p21high	 senescent-like	cell	population.	Currently,	 there	 is	
limited knowledge about in vivo senescent cells due to the difficulty 
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in isolating them because of their low numbers and lack of ideal mark-
ers.	 To	our	 knowledge,	we	obtained	 the	 transcriptomic	 signatures	
of in vivo p21high	senescent-like	cells	for	the	first	time,	which	could	
assist in understanding the biology of senescence and drug develop-
ment.	In	addition,	we	uncovered	many	signaling	pathways	that	vary	
between	ADSCs	isolated	from	young	versus	old	donors.	Our	study	





outcomes of transplantation for older patients.
F I G U R E  1  Adipose-derived	mesenchymal	stem	cell	(ADSCs)	from	old	donors	impair	physical	function.	(a)	Experimental	design.	(b-e)	
Quantification	of	maximal	walking	speed	(relative	to	baseline)	(b),	grip	strength	(c),	hanging	endurance	(d),	daily	activity	(e)	of	21-month-old	
male	C57BL/6	mice	4–6	weeks	after	being	injected	with	1	×	106	ADSCs	from	old	or	young	donors	or	no	(sham)	ADSCs.	For	b,	c,	d,	n = 10 for 
sham,	n	=	9	for	Young,	n	=	9	for	old.	For	e,	n = 8 for all groups. Results are mean ± SEM.	*,	p	<	.05;	Student's	t test
F I G U R E  2  Single-cell	transcriptome	analysis.	(a)	Violin	plots	for	p21 and p16	expression	levels	in	young	and	old	cell	populations.	(b)	IPA	
analysis of p21high	cells.	Positive	Z-score	indicates	up-regulation	in	p21high	cells.	(c)	Volcano	plot	of	differentially	expressed	genes	between	
cells	from	young	and	old	donors.	The	top	20	most	significantly	altered	genes,	and	several	selected	genes	are	highlighted.	–log10	P	value	and	
log2(fold	change)	values	are	shown.	(d)	Secreted	cytokine	levels	in	conditioned	media	from	ADSCs	isolated	from	young	and	old	donors.	n = 4. 
Results are mean ± SEM.	*,	p	<	.05;	Student's	t	test.	(e)	IPA	analysis	of	canonical	pathways	enriched	in	adipose-derived	mesenchymal	stem	
cell	(ADSCs)	from	old	versus	young	donors
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